126 related articles for article (PubMed ID: 22290745)
1. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
Lacey JV; Chia VM; Rush BB; Carreon DJ; Richesson DA; Ioffe OB; Ronnett BM; Chatterjee N; Langholz B; Sherman ME; Glass AG
Int J Cancer; 2012 Oct; 131(8):1921-9. PubMed ID: 22290745
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.
Zhao J; Hu Y; Zhao Y; Chen D; Fang T; Ding M
BMC Womens Health; 2021 Aug; 21(1):312. PubMed ID: 34433451
[TBL] [Abstract][Full Text] [Related]
3. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
Lacey JV; Sherman ME; Rush BB; Ronnett BM; Ioffe OB; Duggan MA; Glass AG; Richesson DA; Chatterjee N; Langholz B
J Clin Oncol; 2010 Feb; 28(5):788-92. PubMed ID: 20065186
[TBL] [Abstract][Full Text] [Related]
4. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital.
Sirimusika N; Peeyananjarassri K; Suphasynth Y; Wootipoom V; Kanjanapradit K; Geater A
J Med Assoc Thai; 2014 Mar; 97(3):260-6. PubMed ID: 25123004
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of endometrial hyperplasia.
Armstrong AJ; Hurd WW; Elguero S; Barker NM; Zanotti KM
J Minim Invasive Gynecol; 2012; 19(5):562-71. PubMed ID: 22863972
[TBL] [Abstract][Full Text] [Related]
6. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
Janicek MF; Rosenshein NB
Gynecol Oncol; 1994 Mar; 52(3):373-8. PubMed ID: 8157194
[TBL] [Abstract][Full Text] [Related]
7. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
[TBL] [Abstract][Full Text] [Related]
8. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
9. The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study.
van Meurs HS; Bleeker MC; van der Velden J; Overbeek LI; Kenter GG; Buist MR
Int J Gynecol Cancer; 2013 Oct; 23(8):1417-22. PubMed ID: 24257556
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
[TBL] [Abstract][Full Text] [Related]
11. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
[TBL] [Abstract][Full Text] [Related]
12. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
Bilgin T; Ozuysal S; Ozan H; Atakan T
J Obstet Gynaecol Res; 2004 Jun; 30(3):205-9. PubMed ID: 15210044
[TBL] [Abstract][Full Text] [Related]
13. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
14. Preoperative and postoperative agreement of histopathological findings in cases of endometrial hyperplasia.
Kleebkaow P; Maneetab S; Somboonporn W; Seejornj K; Thinkhamrop J; Kamwilaisak R
Asian Pac J Cancer Prev; 2008; 9(1):89-91. PubMed ID: 18439083
[TBL] [Abstract][Full Text] [Related]
15. Association of endometrial hyperplasia and cancer with a history of gestational diabetes.
Wartko PD; Beck TL; Reed SD; Mueller BA; Hawes SE
Cancer Causes Control; 2017 Aug; 28(8):819-828. PubMed ID: 28577154
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
Lacey JV; Ioffe OB; Ronnett BM; Rush BB; Richesson DA; Chatterjee N; Langholz B; Glass AG; Sherman ME
Br J Cancer; 2008 Jan; 98(1):45-53. PubMed ID: 18026193
[TBL] [Abstract][Full Text] [Related]
18. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
[TBL] [Abstract][Full Text] [Related]
19. Does the type of hysterectomy affect the prognosis in clinical stage I endometrial cancer?
Han CH; Lee KH; Lee HN; Kim CJ; Park TC; Park JS
J Obstet Gynaecol Res; 2010 Jun; 36(3):581-7. PubMed ID: 20598041
[TBL] [Abstract][Full Text] [Related]
20. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
